POLA PERESEPAN ANTIBIOTIK PADA PASIEN ANAK DENGAN INFEKSI PERNAPASAN AKUT
Isi Artikel Utama
Abstrak
Prescriptions for children who experience upper and lower acute respiratory infections (ARI), such as the common cold, rhinitis, sinusitis, pharyngitis and tonsillitis, are carried out according to the pattern. The study aimed to determine the pattern of antibiotic prescribing in pediatric ARI patients at the Karadiri Community Health Center, Nabire Regency. This type of descriptive research uses secondary data, namely medical records of antibiotic prescriptions in pediatric patients with ARI. The sample was all medical records of pediatric patients treated with ARI at the Karadiri Community Health Center, Nabire Regency, totaling 92 respondents. Sample selection with inclusion criteria is complete data, residents who live in the work area of the health center, and exclusion is incomplete data and non-residents who are disabled in the work area of the health center. The instrument uses an observation sheet. The results showed that the majority of ARI patients were aged 2-5 years (85%) and male (54%). The antibiotics used were amoxicillin in 58 patients (63%), followed by Co-trimoxazole in 25 (27%), Erythromycin in 9 (10%). The most commonly prescribed antibiotic dose was amoxicillin 66.7 mg (32%) with 24 prescriptions (26%). The duration of antibiotic administration was 5 days for 89 prescriptions (97%), with 67 prescriptions (75%) meeting the guidelines. In conclusion, the prescription of antibiotics for pediatric patients with ARI is not fully in accordance with the guidelines, namely the duration is 4 days and the dose follows the patient's body weight.
Rincian Artikel
Referensi
L. Maccioni et al., “Obesity and risk of respiratory tract infections: Results of an infection-diary based cohort study,” BMC Public Health, vol. 18, no. 1, pp. 1–13, 2018, doi: 10.1186/s12889-018-5172-8.
F. Fathmawati, S. Rauf, and B. W. Indraswari, “Factors Related with The Incidence of Acute Respiratory Infections in Toddlers in Sleman, Yogyakarta, Indonesia: Evidence From The Sleman Health and Demographic Surveillance System,” PLoS One, no. 9 September, pp. 1–13, 2021, doi: 10.1371/journal.pone.0257881.
P. Bertrand and I. Sánchez, “Pediatric Respiratory Diseases: A Comprehensive Textbook,” Pediatr. Respir. Dis. A Compr. Textb., pp. 1–807, 2020, doi: 10.1007/978-3-030-26961-6.
S. Hong et al., “Epidemiology of respiratory pathogens in patients with acute respiratory tract infection in Xiamen, China: A retrospective survey from 2020 to 2022,” Heliyon, vol. 9, no. 11, p. e22302, 2023, doi: 10.1016/j.heliyon.2023.e22302.
J. Yu et al., “Comparison of the prevalence of respiratory viruses in patients with acute respiratory infections at different hospital settings in North China, 2012-2015,” BMC Infect. Dis., vol. 18, no. 1, pp. 1–10, 2018, doi: 10.1186/s12879-018-2982-3.
S. Q. Bham, F. Saeed, and M. A. Shah, “Knowledge, Attitude and Practice of mothers on acute respiratory infection in children under five years,” Pakistan J. Med. Sci., vol. 32, no. 6, pp. 1557–1561, 2016, doi: 10.12669/pjms.326.10788.
J. Hawkins, C. Baker, L. Cherry, and E. Dunne, “Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta-analysis of randomized, controlled clinical trials,” Complement. Ther. Med., vol. 42, pp. 361–365, 2019, doi: 10.1016/j.ctim.2018.12.004.
M. M. J. Al Sous, H. N. Al Houri, M. H. Safiah, S. O. Alazrak, and R. R. Akwan, “Antibiotic prescription patterns for acute upper respiratory tract infections in an outpatient population with health insurance in Syria — a retrospective cross-sectional study,” IJID Reg., vol. 7, no. January, pp. 66–71, 2023, doi: 10.1016/j.ijregi.2023.02.010.
C. Llor and L. Bjerrum, “Antimicrobial resistance: Risk associated with antibiotic overuse and initiatives to reduce the problem,” Ther. Adv. Drug Saf., vol. 5, no. 6, pp. 229–241, 2014, doi: 10.1177/2042098614554919.
N. K. Ganguly et al., “Rationalizing antibiotic use to limit antibiotic resistance in india,” Indian J. Med. Res., vol. 134, no. 9, pp. 281–294, 2011.
J. Thinkhamrop, G. J. Hofmeyr, O. Adetoro, P. Lumbiganon, and E. Ota, “Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidity,” Cochrane database Syst. Rev., vol. 6, p. CD002250, 2015, doi: 10.1002/14651858.CD002250.pub3.
F. M. Smaill and J. C. Vazquez, “Antibiotics for asymptomatic bacteriuria in pregnancy,” Cochrane Database Syst. Rev., vol. 2019, no. 11, pp. 1–50, 2019, doi: 10.1002/14651858.CD000490.pub4.
D. P. Legendre, C. A. Muzny, G. D. Marshall, and E. Swiatlo, “Antibiotic hypersensitivity reactions and approaches to desensitization,” Clin. Infect. Dis., vol. 58, no. 8, pp. 1140–1148, 2014, doi: 10.1093/cid/cit949.
A. Jourdan et al., “Antibiotic hypersensitivity and adverse reactions: Management and implications in clinical practice,” Allergy, Asthma Clin. Immunol., vol. 16, no. 1, pp. 1–7, 2020, doi: 10.1186/s13223-020-0402-x.
Liliana Serweci´nska, “Antimicrobials and Antibiotic-Resistant Bacteria :,” Water, vol. 12, pp. 3313–3330, 2020.
T. M. Uddin et al., “Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects,” J. Infect. Public Health, vol. 14, no. 12, pp. 1750–1766, 2021, doi: 10.1016/j.jiph.2021.10.020.
A. Dalhoff, “Selective toxicity of antibacterial agents—still a valid concept or do we miss chances and ignore risks?,” Infection, vol. 49, no. 1, pp. 29–56, 2021, doi: 10.1007/s15010-020-01536-y.
P. Makvandi et al., “Bioengineered materials with selective antimicrobial toxicity in biomedicine,” Mil. Med. Res., vol. 10, no. 1, pp. 1–20, 2023, doi: 10.1186/s40779-023-00443-1.
S. Leekha, C. L. Terrell, and R. S. Edson, “General principles of antimicrobial therapy,” Mayo Clin. Proc., vol. 86, no. 2, pp. 156–167, 2011, doi: 10.4065/mcp.2010.0639.
D. Chinemerem Nwobodo et al., “Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace,” J. Clin. Lab. Anal., vol. 36, no. 9, pp. 1–10, 2022, doi: 10.1002/jcla.24655.
M. E. A. de Kraker, A. J. Stewardson, and S. Harbarth, “Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?,” PLoS Med., vol. 13, no. 11, pp. 1–6, 2016, doi: 10.1371/journal.pmed.1002184.
H. Karuniawati, M. A. A. Hassali, S. Suryawati, W. I. Ismail, T. Taufik, and M. S. Hossain, “Assessment of knowledge, attitude, and practice of antibiotic use among the population of boyolali, indonesia: A cross-sectional study,” Int. J. Environ. Res. Public Health, vol. 18, no. 16, 2021, doi: 10.3390/ijerph18168258.
A. B. Siddik et al., “Bacterial and viral etiology of acute respiratory infection among the Forcibly Displaced Myanmar Nationals (FDMNs) in fragile settings in Cox’s Bazar-a prospective case-control study,” PLoS Negl. Trop. Dis., vol. 17, no. 4, pp. 1–28, 2023, doi: 10.1371/journal.pntd.0011189.
D. Assane et al., “Viral and Bacterial Etiologies of Acute Respiratory Infections Among Children Under 5 Years in Senegal,” Microbiol. Insights, vol. 11, p. 117863611875865, 2018, doi: 10.1177/1178636118758651.
G. S. Bhuyan et al., “Bacterial and viral pathogen spectra of acute respiratory infections in under-5 children in hospital settings in Dhaka city,” PLoS One, vol. 12, no. 3, pp. 1–21, 2017, doi: 10.1371/journal.pone.0174488.
A. C. Kalil and P. G. Thomas, “Influenza Fisiopatología,” Crit. Care, vol. 23, no. 258, pp. 1–7, 2019.
C. R. MacIntyre et al., “Respiratory viruses transmission from children to adults within a household,” Vaccine, vol. 30, no. 19, pp. 3009–3014, 2012, doi: 10.1016/j.vaccine.2011.11.047.
K. Kondratiuk, E. Hallmann, K. Luniewska, K. Szymanski, and L. B. Brydak, “Epidemiology of influenza viruses and viruses causing influenza-like illness in children under 14 years old in the 2018-2019 epidemic season in Poland,” Med. Sci. Monit., vol. 27, pp. 1–7, 2021, doi: 10.12659/MSM.929303.
S. S. Aithal, I. Sachdeva, and O. P. Kurmi, “Air quality and respiratory health in children,” Breathe, vol. 19, no. 2, pp. 1–6, 2023, doi: 10.1183/20734735.0040-2023.
A. A. Tazinya, G. E. Halle-Ekane, L. T. Mbuagbaw, M. Abanda, J. Atashili, and M. T. Obama, “Risk factors for acute respiratory infections in children under five years attending the Bamenda Regional Hospital in Cameroon,” BMC Pulm. Med., vol. 18, no. 1, pp. 1–8, 2018, doi: 10.1186/s12890-018-0579-7.
S. Chowdhury and P. pratim Chakraborty, “Universal health coverage ‑ There is more to it than meets the eye,” J. Fam. Med. Prim. Care, vol. 6, no. 2, pp. 169–170, 2017, doi: 10.4103/jfmpc.jfmpc.
L. Sulistyorini, C. Y. Li, L. Lutpiatina, R. D. Utama, and Nurlailah, “Gendered Impact of Age, Toilet Facilities, and Cooking Fuels on the Occurrence of Acute Respiratory Infections in Toddlers in Indonesia and the Philippines,” Int. J. Environ. Res. Public Health, vol. 19, no. 21, pp. 1–17, 2022, doi: 10.3390/ijerph192114582.
H. Kadry, B. Noorani, and L. Cucullo, “A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity,” Fluids Barriers CNS, vol. 17, no. 1, pp. 1–24, 2020, doi: 10.1186/s12987-020-00230-3.
W. M. Pardridge, “Drug transport in brain via the cerebrospinal fluid,” Fluids Barriers CNS, vol. 8, no. 1, p. 7, 2011, doi: 10.1186/2045-8118-8-7.
R. Nau, F. Sörgel, and H. Eiffert, “Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections,” Clin. Microbiol. Rev., vol. 23, no. 4, pp. 858–883, 2010, doi: 10.1128/CMR.00007-10.
E. Hobeika et al., “Are antibiotics substandard in Lebanon? Quantification of active pharmaceutical ingredients between brand and generics of selected antibiotics,” BMC Pharmacol. Toxicol., vol. 21, no. 1, pp. 1–12, 2020, doi: 10.1186/s40360-020-0390-y.
F. Riu et al., “Antibiotics and Carbohydrate-Containing Drugs Targeting Bacterial Cell Envelopes: An Overview,” Pharmaceuticals, vol. 15, no. 8, pp. 1–38, 2022, doi: 10.3390/ph15080942.
G. Xiao, J. Li, and Z. Sun, “The Combination of Antibiotic and Non-Antibiotic Compounds Improves Antibiotic Efficacy against Multidrug-Resistant Bacteria,” Int. J. Mol. Sci., vol. 24, no. 20, 2023, doi: 10.3390/ijms242015493.
M. E. Levison and J. H. Levison, “Pharmacokinetics and Pharmacodynamics of Antibacterial Agents,” Infect. Dis. Clin. North Am., vol. 23, no. 4, pp. 791–815, 2009, doi: 10.1016/j.idc.2009.06.008.
N. Wang, J. Luo, F. Deng, Y. Huang, and H. Zhou, “Antibiotic Combination Therapy: A Strategy to Overcome Bacterial Resistance to Aminoglycoside Antibiotics,” Front. Pharmacol., vol. 13, no. February, pp. 1–15, 2022, doi: 10.3389/fphar.2022.839808.
K. Upadhya R, L. Shenoy, and R. Venkateswaran, “Effect of intravenous dexmedetomidine administered as bolus or as bolus-plus-infusion on subarachnoid anesthesia with hyperbaric bupivacaine,” J. Anaesthesiol. Clin. Pharmacol., vol. 34, no. 3, pp. 46–50, 2018, doi: 10.4103/joacp.JOACP.
F. Prestinaci, P. Pezzotti, and A. Pantosti, “Antimicrobial resistance: A global multifaceted phenomenon,” Pathog. Glob. Health, vol. 109, no. 7, pp. 309–318, 2015, doi: 10.1179/2047773215Y.0000000030.
R. Ofori-Asenso and A. Agyeman, “Irrational Use of Medicines—A Summary of Key Concepts,” Pharmacy, vol. 4, no. 4, p. 35, 2016, doi: 10.3390/pharmacy4040035.
G. P. Velo and P. Minuz, “Medication errors: Prescribing faults and prescription errors,” Br. J. Clin. Pharmacol., vol. 67, no. 6, pp. 624–628, 2009, doi: 10.1111/j.1365-2125.2009.03425.x.